Hypoglycemia in a healthy toddler

Therapeutic Drug Monitoring

Volumn 31, Issue 2, 2009, Pages 173-177

  Glatstein, Miguel ^a   Garcia Bournissen, Facundo ^a   Scolnik, Dennis ^a   Koren, Gideon ^a   Finkelstein, Yaron ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Children; Hypoglycemia; Munchausen syndrome by proxy; Sulfonylurea

Indexed keywords

GLUCOSE; SULFONYLUREA; ANTIDIABETIC AGENT; GLIBENCLAMIDE;

ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; HYPOGLYCEMIA; INTOXICATION; MENTAL HEALTH; MUNCHAUSEN SYNDROME BY PROXY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCHOOL CHILD; PRIORITY JOURNAL; TODDLER; CHEMICALLY INDUCED DISORDER; INFANT;

GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT;

EID: 65349115891     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318197b7d7     Document Type: Article

References (50)

1. Pershad J, Monroe K, Atchison J. Childhood hypoglycemia in an urban emergency department: epidemiology and diagnostic approach to the problem. Pediatr Emerg Care. 1998;14:268-271.
2. Taylor SI, Barbetti F, Accuku D, et al. Syndromes of autoimmunity and hypoglycemia: autoantibodies directed against insulin and its receptor. Endocrinol Metab Clin North Am. 1989;18:123-143.
3. Sperling MA. Hypoglycemia. In: Kliegman RM, Behrman RE, Jenson HB, Stanton, BF, eds. Nelson's Textbook of Pediatrics. 18th ed. Philadelphia: W.B. Saunders Company, 2007:655-669.
4. Brust JC. Seizures, illicit drugs, and ethanol. Curr Neurol Neurosci Rep. 2008;8:333-338.
5. Brunelle F, Negre V, Barth MO, et al. Pancreatic venous samplings in infants and children with primary hyperinsulinism. Pediatr Radiol. 1989;19:100-103.
6. Edidin DV, Farrel EE, Gould VE. Factitious hyperinsulinemic hypoglycemia in infancy: diagnostic pitfalls. Clin Pediatr (Phila). 2000;39:117-119.
7. Little GL, Boniface KS. Are one or two dangerous? Sulfonylurea exposure in toddlers. J Emerg Med. 2005;28:305-306.
8. Goñi González T, Martínez Roda MJ, de la Cerda Ojeda F, et al. Munchausen syndrome by proxy. An Pediatr (Barc). 2008;68:609-611.
9. Natahn DM, Rousell A, Godine JE. Glyburide or insulin form metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study. Ann Intern Med. 1988;108:334-340.
10. Quadrani DA, Spiller HA, Widder P. Five year retrospective evaluation of sulphonylureas ingestion in children. J Toxicol Clin Toxicol. 1996;34:267-270.
11. Kempe CH, Silverman FN, Steele BF, et al. The battered child syndrome. JAMA. 1963;17:181.
12. Lai MW, Klein-Schwartz W, Rodgers GC, et al. 2005 Annual report of the American Association of Poison Control Centers' national poisoning and exposure database. Clin Toxicol (Phila). 2006;44:803-932.
13. Owen L, Ellis M, Shield J. Deliberate sulphonylurea poisoning mimicking hyperinsulinaemia of infancy. Arch Dis Child. 2000;82:392-393.
14. La Franchi S. Hypoglycaemia of infancy and childhood. Pediatr Clin North Am. 1987;34:961.
15. Vialettes B, Vague P. The clinical value of C-peptide assay. Diabetes Metab. 1980;6:225.
16. Dimitriadis G, Raptis S, Zoupas C, et al. The validity of C-peptide measurement in the diagnosis of factitious hypoglycemia. Acta Diabetol Lat. 1980;17:67-71.
17. Hussain K, Mundi H, Aynsley-Green A, et al. A child presenting with disordered consciousness, hallucinations, screaming episodes and abdominal pain. Eur J Pediatr. 2002;161:127-129.
18. 2+ in mouse pancreatic B-cells following stimulation by hypoglycemic sulphonylureas. FEBS Lett. 1985;190:21-24.
19. Gerich JE. Oral hypoglycemic agents. N Engl J Med. 1989;321:1231-1245.
20. Meadow R. Different interpretations of Munchausen syndrome. Child Abuse Negl. 2003;26:501-508.
21. McClure RJ, Davies PM, Meadows SR, et al. Epidemiology of Munchausen syndrome by proxy, non-accidental poisoning, and non accidental suffocation. Arch Dis Child. 1996;75:57-61.
22. Aranibar H, Cerda M. Hypoglycemic seizure in Munchausen-by-proxy syndrome. Pediatr Emerg Care. 21;6:378-379.
23. Greenberg B, Weilhl C, Hug G. Chlorpropamide poisoning. Pediatrics. 1968;41:145-147.
24. Szlatenyi CS, Capes KF, Wang RY. Delayed hypoglycemia in a child after ingestion of a single glipizide table. Ann Emerg Med. 1998;31:773-776.
25. Spiller HA, Schoeder SL, Ching DS. Hemiparesis and altered mental status in a child after glyburide ingestion. J Emerg Med. 1998;16:433-435.
26. Bar-Oz B, Amitai Y. Overdosage of glibenclamide presenting with lethargy and seizure in a child. Harefuah. 1992;123:165-166, 232, 235.
27. Wasowicz Z, Klys J, Mikosz R. Acute suicidal poisoning with oral hypoglycemic agents (artosin and chloronase) in a 12-year-old boy. Wiad lek. 1974;27:1095-1097.
28. Lemke R. Fatal iatrogenically-induced hyperglycemia following accidental glibenclamide ingestion. Klin Pediatr. 1990;202:103-105.
29. Ramos E, Baron S, Sentanac S, et al. Hypoglycemia associated with oral sulfonylurea hypoglycaemic agents in an 11-year-old girl. Arch Pediatr. 2005;12:1109-1111.
30. Giurgea I, Ulinski T, Touati G, et al. Factitious hyperinsulinism leading to pancreatectomy: severe forms of Munchausen syndrome by proxy. Pediatrics. 2005;116:e145-e148.
31. Pavone L, Mollica F, Musumeci S, et al. Accidental ingestion in an infant, clinical and electroencephalographic aspects. Dev Med Child Neurol. 1980;22:366-371.
32. Mordel A, Sukvukittu NKA, Old AC, et al. Octreotide for pediatric sulphonylurea poisoning. J Toxicol Clin Toxicol. 1998;36:437.
33. Kent DA, Main BA, Friesen MS. Use of octreotide in sulphonylurea poisoning in a child. J Toxicol Clin Toxicol. 2003;41:669.
34. Calello DP, Kelly A, Osterhoudt KC. Case files of the Medical Toxicology Fellowship Training Program at the Children's Hospital of Philadelphia: a pediatric exploratory sulfonylurea ingestion. J Med Toxicol. 2006;2:19-24.
35. Rath S, Bar-Zeev N, Anderson K, et al. Octreotide in children with hypoglycaemia due to sulfonylurea ingestion. J Paediatr Child Health. 2008;44:383-384.
36. Caksen H, Kendirci M, Tutus A, et al. Gliclazide-induced hepatitis, hemiplegia and dysphasia in a suicidal attempt. J Pediatr Endocrinol Metab. 2001;14:1157-1159.
37. Vanelli M. Munchausen's syndrome by proxy web-mediated in a child with factitious hyperglycemia. J Pediatr. 2002;141:839.
38. Teale JD, Starkey BJ, Marks V. The prevalence of factitious hypoglycaemia due to sulphonylurea abuse in the UK. A preliminary report. Pract Diabetes. 1989;6:177-178.
39. Litovitz TL, Klein Scwartz W, Dyer KS, et al. 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1998;16:443-447.
40. Matteucci MJ. One pill can kill: assessing the potential for fatal poisoning in children. Pediatr Ann. 2005;34:964.
41. Harrigan RA, Nathan MS, Beattie P. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Ann Emerg Med. 2001;38:68-78.
42. AHFS Drug Information. Vol 68. American Hospital Formulary Service Board of the American Society of Health System Pharmacists; Bethesda, MD, 1998:2595-2597.
43. Haymond MW. Hypoglycemia in infants and children. Endocrinol Metab Clin North Am. 1989;18:211-252.
44. Tricarico D, Capriulo R, Conte Camerino D. Insulin modulation of ATP-sensitive K = channel of rat skeletal is impaired in the hypokalaemic state. Pflugers Arch. 1999;437:235-240.
45. Lheureux PER, Zahir S, Penaloza A, et al. Bench-to-bedside review: antidotal treatment of sulphonylurea-induced hypoglycaemia with octreotide. Crit Care. 2005;9:543-549.
46. Lhereux PE, Zahir S, Penaloza A, et al. Bench-to bedside review: antidotal treatment of sulphonylurea-induced hypoglycaemia with octreotide. Crit Care. 2005;9:543-549.
47. Graudins A, Linden CH, FermRP. Diagnosis and treatment of sulphonylurea-induced hyperinsulinaemic hypoglycemia. Am J Emerg Med. 1997;15:95-96.
48. Johnson SF, Schade DS, Peake GT. Chlorpropamide-induced hypoglycemia: successful treatment with diazoxide. Am J Med. 1977;63:799-804.
49. McLaughlin SA, Crandall CS, McKinney PE. Octreotide: an antidote for sulphonylurea-induced hypoglycemia. Ann Emerg Med. 2000;36:133-138.
50. Glaser B, Hirsch HJ, Landau H. Persistent hyperinsulinaemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr. 1993;123:644-650.